{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:23:02Z","timestamp":1767900182872,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21390273"],"award-info":[{"award-number":["21390273"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H23-017"],"award-info":[{"award-number":["H23-017"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jneuroim.2012.09.005","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T01:45:21Z","timestamp":1348191921000},"page":"141-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An antibody to the GM1\/GalNAc-GD1a complex correlates with development of pure motor Guillain\u2013Barr\u00e9 syndrome with reversible conduction failure"],"prefix":"10.1016","volume":"254","author":[{"given":"Go","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kamakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.09.005_bb0005","first-page":"S225","article-title":"Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block","volume":"8","author":"American Association of Electrodiagnostic Medicine","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0010","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.61.5.617","article-title":"Acute motor conduction block neuropathy: another Guillain\u2013Barr\u00e9 syndrome variant","volume":"61","author":"Capasso","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neucli.2008.02.004","article-title":"Acute motor conduction block neuropathy pattern occurring in the course of an acute inflammatory demyelinating polyradiculoneuropathy","volume":"38","author":"Fern\u00e1ndez-Torre","year":"2008","journal-title":"Neurophysiol. Clin."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.58.6.913","article-title":"Early electrodiagnostic findings in Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Gordon","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0040","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/01.WNL.0000153071.71335.E9","article-title":"Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain\u2013Barr\u00e9 syndrome","volume":"64","author":"Hiraga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1529-8027.2011.00314.x","article-title":"Axonal conduction block at intermediate nerve segments in pure motor Guillain\u2013Barr\u00e9 syndrome","volume":"16","author":"Hong","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0055","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain\u2013Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","article-title":"GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody","volume":"61","author":"Kaida","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes: as new target antigens in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0080","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex: a target for pure motor Guillain\u2013Barr\u00e9 syndrome","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0085","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain\u2013Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain\u2013Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5692\/clinicalneurol.49.488","article-title":"Case of pure motor Guillain\u2013Barr\u00e9 syndrome with motor conduction block and anti-GM1\/GalNAc-GD1a antibody","volume":"49","author":"Ogawa","year":"2009","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0105","first-page":"42","article-title":"A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis","volume":"38","author":"Sugie","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2012.09.005_bb0110","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:55Z","timestamp":1759047595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812002780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0165572812002780"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.09.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An antibody to the GM1\/GalNAc-GD1a complex correlates with development of pure motor Guillain\u2013Barr\u00e9 syndrome with reversible conduction failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}